Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 • 3,065 citations
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
2003 • 2,402 citations
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
2003 • 1,862 citations
Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus
2002 • 794 citations
The Effect of Prescribed Daily Dose Frequency on Patient Medication Compliance
1990 • 788 citations
Tissue Angiotensin and Pathobiology of Vascular Disease
2001 • 750 citations
Structure-based design of aliskiren, a novel orally effective renin inhibitor
2003 • 499 citations
Drugs targeting the renin–angiotensin–aldosterone system
2002 • 425 citations
Angiotensin II Suppression in Humans by the Orally Active Renin Inhibitor Aliskiren (SPP100)
2002 • 409 citations
Pathways for Angiotensin II Generation in Intact Human Tissue
1998 • 338 citations
Blood Pressure Lowering in Essential Hypertension With an Oral Renin Inhibitor, Aliskiren
2003 • 338 citations
Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin
2000 • 310 citations
Pharmacokinetics and Pharmacodynamics of Irbesartan in Healthy Subjects
1998 • 73 citations
Calcium antagonists and renal protection
1993 • 72 citations
Is there a future for renin inhibitors?
2001 • 69 citations
Review: Potential of renin inhibition in cardiovascular disease
2003 • 66 citations
Cough and inhibition of the renin-angiotensin system.
1993 • 62 citations
Low-dose combination therapy: an important first-line treatment in the management of hypertension
2001 • 60 citations
Pharmacology of renin inhibitors and their application to the treatment of hypertension
1994 • 46 citations
Irbesartan
2000 • 44 citations
Renin inhibitors as novel treatments for cardiovascular disease
2003 • 43 citations
Clinical Pharmacokinetics and Efficacy of Renin Inhibitors
1995 • 38 citations
Alterations in cytosolic calcium-binding proteins that increase felodipine fluorescence in spontaneously hypertensive rats
1993 • 14 citations
Role of trough to peak efficacy in the evaluation of antihypertensive therapy.
1998 • 7 citations